Dale I Godfrey Selected Research

COVID-19

1/2022	SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity.
11/2021	Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice.
1/2021	Influenza, but not SARS-CoV-2, infection induces a rapid interferon response that wanes with age and diminished tissue-resident memory CD8+ T cells.
1/2021	Integrated immune dynamics define correlates of COVID-19 severity and antibody responses.
1/2020	Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dale I Godfrey Research Topics

Disease

26	Neoplasms (Cancer) 01/2022 - 01/2002
18	Infections 01/2022 - 09/2005
7	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2002
5	COVID-19 01/2022 - 01/2020
5	Autoimmune Diseases (Autoimmune Disease) 12/2011 - 02/2002
4	Inflammation (Inflammations) 01/2022 - 11/2014
4	Lymphoma (Lymphomas) 09/2013 - 03/2004
3	Malaria 01/2020 - 10/2016
3	Sarcoma (Soft Tissue Sarcoma) 12/2009 - 07/2002
2	Human Influenza (Influenza) 01/2021 - 11/2017
2	Tuberculosis (Tuberculoses) 01/2018 - 07/2013
2	Leukemia 06/2015 - 11/2005
2	Melanoma (Melanoma, Malignant) 10/2013 - 11/2005
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2011 - 09/2008
2	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2009 - 11/2005
2	B-Cell Lymphoma (Lymphoma, B Cell) 02/2009 - 03/2004
2	Hypersensitivity (Allergy) 03/2007 - 04/2003
1	Noncommunicable Diseases 01/2019
1	Polyps 01/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2019
1	Multiple Myeloma 01/2016
1	Lymphopenia (Lymphocytopenia) 01/2016
1	HIV Infections (HIV Infection) 02/2015
1	Asthma (Bronchial Asthma) 10/2013
1	Eczema 09/2013
1	Bacterial Infections (Bacterial Infection) 09/2013
1	Liver Diseases (Liver Disease) 12/2011
1	Crohn Disease (Crohn's Disease) 12/2011
1	Experimental Melanoma 12/2009
1	Carcinoma (Carcinomatosis) 12/2009
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2008
1	Persistent Infection 02/2008

Drug/Important Bio-Agent (IBA)

14	CytokinesIBA 01/2022 - 02/2002
13	AntigensIBA 01/2022 - 03/2010
9	alpha-galactosylceramideIBA 09/2008 - 02/2002
6	PerforinIBA 01/2018 - 01/2002
6	Interleukin-12 (IL 12)IBA 02/2006 - 02/2002
5	VaccinesIBA 12/2021 - 10/2016
5	interleukin-21 (interleukin 21)IBA 10/2013 - 06/2005
4	LipidsIBA 01/2017 - 03/2010
3	Interleukin-18 (Interleukin 18)IBA 01/2021 - 02/2002
3	AntibodiesIBA 01/2020 - 12/2011
3	GlycolipidsIBA 01/2020 - 10/2013
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 07/2002
3	Riboflavin (Vitamin B2)FDA LinkGeneric 12/2019 - 12/2015
3	Granzymes (Granzyme)IBA 11/2018 - 06/2004
3	MethylcholanthreneIBA 12/2009 - 07/2002
3	LigandsIBA 12/2009 - 02/2002
3	Interleukin-4 (Interleukin 4)IBA 02/2008 - 02/2002
2	AutoantigensIBA 01/2022 - 02/2002
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2015
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021 - 01/2018
2	InterferonsIBA 01/2021 - 10/2013
2	InterleukinsIBA 01/2019 - 07/2002
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2019
2	Galactosylceramides (Galactocerebrosides)IBA 01/2018 - 01/2018
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2009 - 11/2005
2	Interferon-gamma (Interferon, gamma)IBA 02/2002 - 01/2002
1	ChemokinesIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Disinfectants (Biocides)IBA 01/2022
1	Neutralizing AntibodiesIBA 11/2021
1	SuspensionsIBA 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Interferon Type IIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2020
1	RezafunginIBA 01/2020
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2020
1	EpitopesIBA 01/2020
1	Toll-Like Receptor AgonistsIBA 12/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	ChromatinIBA 01/2019
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 01/2019
1	sulfoglycolipidsIBA 01/2018
1	Antiparasitic Agents (Antiparasitics)IBA 01/2018
1	EstersIBA 01/2018
1	safingol (sphinganine)IBA 01/2018
1	SugarsIBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	Protein Subunit VaccinesIBA 11/2017
1	Pharmaceutical PreparationsIBA 01/2016
1	pyrimidineIBA 12/2015
1	Transcription Factors (Transcription Factor)IBA 06/2015
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 11/2014
1	GlucocorticoidsIBA 11/2014
1	IntegrinsIBA 09/2013
1	Complement Factor B (Factor B)IBA 09/2013
1	Immunoglobulin E (IgE)IBA 09/2013
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 09/2013
1	VitaminsIBA 11/2012
1	Non-Receptor Type 2 Protein Tyrosine PhosphataseIBA 12/2011

Therapy/Procedure

7	Immunotherapy 01/2021 - 04/2002
4	Therapeutics 11/2021 - 10/2002
1	Drug Therapy (Chemotherapy) 01/2022
1	Transplantation 04/2009